Rajnish Wellness Peer Comparison

BSE: 541601

₹0.36

₹0.01 (2.86%)

As on 04-Nov-2026IST

Market cap

₹37 Cr

Revenue (TTM)

₹168 Cr

P/E Ratio

--

P/B Ratio

0.4

Div. Yield

0 %

Edit

	Rajnish Wellness	Emami	Zydus Wellness	Jyothy Labs	Bajaj Consumer
Market cap (₹ Cr)	37	16,380	15,547	6,915	5,269
Revenue (₹ Cr)	168	3,915	5,013	2,990	1,307
Net Profit (₹ Cr)	-5.42	753.50	246.10	206.88	250.86
Net Margin (%)	-3.21	18.85	4.90	6.77	18.79
RoE (%)	-5.12	25.89	4.30	13.32	30.36
Price to Earnings	--	21.89	63.17	33.43	21.00
Price-To-Book	0.36	5.89	2.63	4.23	5.87

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Rajnish Wellness	Emami	Zydus Wellness	Jyothy Labs	Bajaj Consumer
Operating Revenue	168.21	3,914.63	5,013.20	2,990.46	1,307.15
Total Income	169.00	3,996.65	5,025.40	3,054.88	1,335.24
Total Expenditure	176.59	2,939.02	4,354.90	2,699.17	1,008.83
EBITDA	-8.38	975.61	658.30	291.29	298.32
Depreciation	0.02	175.60	225.00	64.56	16.76
EBIT	-8.40	800.01	433.30	226.73	281.55
Interest	0.01	14.31	133.40	4.82	1.46
Other Income	0.79	82.02	12.20	64.42	28.09
Exceptional Items	0.00	-10.15	-6.60	0.00	0.00
Profit before Tax	-7.62	857.57	305.50	286.33	308.18
Provision for Tax	-2.20	104.07	59.40	79.45	57.32
Profit after Tax	-5.42	753.50	246.10	206.88	250.86

Liabilities (₹ Cr)

	Rajnish Wellness	Emami	Zydus Wellness	Jyothy Labs	Bajaj Consumer
Shareholder's Funds	102.56	2,923.98	5,907.70	1,517.11	897.65
Minority Interest	0.00	-1.58	0.00	0.00	0.00
Non-Current Liabilities	2.69	75.76	3,706.90	109.94	9.68
Current Liabilities	3.33	838.24	737.50	496.20	161.66
Total Liabilities	108.58	3,830.51	10,189.90	2,911.23	945.13

Assets (₹ Cr)

	Rajnish Wellness	Emami	Zydus Wellness	Jyothy Labs	Bajaj Consumer
Non-Current Assets	22.92	1,839.04	8,727.80	463.28	311.24
Current Assets	83.64	1,934.86	1,469.90	1,512.00	737.86
Total Assets	108.58	3,830.51	10,189.90	2,911.23	945.13
Total Debt*	0.17	122.38	3,186.40	0.00	0.00
Net Current Assets	80.31	1,096.62	732.40	1,015.80	576.21
Contingent Liabilities	--	10.99	450.40	9.61	9.94

Cashflow (₹ Cr)

	Rajnish Wellness	Emami	Zydus Wellness	Jyothy Labs	Bajaj Consumer
Cash From Operating Activities	-8.65	800.53	226.40	412.13	196.92
Cash Flow from Investing Activities	-6.87	-181.14	-2,909.90	-276.95	-14.45
Cash from Financing Activities	24.72	-554.48	2,698.40	-159.77	-196.49
Net Cash Inflow / Outflow	9.20	64.91	14.90	-24.59	-14.02

Ratios

Profitability Ratios

	Rajnish Wellness	Emami	Zydus Wellness	Jyothy Labs	Bajaj Consumer
ROCE (%)	-9.00	29.54	4.42	30.71	31.00
ROE (%)	-5.12	25.89	4.30	13.32	30.36
ROA (%)	-5.42	20.45	2.43	9.75	26.22
EBIT Margin (%)	-5.00	20.44	8.64	7.58	21.54
Net Margin (%)	-3.21	18.85	4.90	6.77	18.79
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

Growth Ratios

	Rajnish Wellness	Emami	Zydus Wellness	Jyothy Labs	Bajaj Consumer
Revenue Growth (%)	356.91	2.82	73.68	4.67	27.71
EBIT Growth (%)	-5,557.14	-5.27	31.66	-44.91	107.87
Net Profit Growth (%)	-5,028.18	-9.02	-2.88	-40.72	83.86
EPS Growth (%)	-3,828.35	-7.37	-83.32	-41.16	92.33
Book Value Growth (%)	21.89	8.50	2.72	14.81	0.78

Valuation Ratios

	Rajnish Wellness	Emami	Zydus Wellness	Jyothy Labs	Bajaj Consumer
Price / Earnings	-6.74	21.98	61.59	33.42	21.00
Price / Book Value	0.36	5.89	2.63	4.23	5.87
Dividend Yield (%)	0.00	2.62	0.25	1.86	0.00
EV/EBITDA	-3.24	16.01	28.28	20.94	16.30
Market Cap (₹ Cr)	40.61	17,158.99	13,549.79	7,237.65	4,532.48

Solvency Ratios

	Rajnish Wellness	Emami	Zydus Wellness	Jyothy Labs	Bajaj Consumer
Debt to Equity	0.00	0.00	0.51	0.00	0.00
Short term debt to equity ratio	--	0.04	0.03	--	--
Current Ratio	25.12	2.31	1.99	3.05	4.56
Quick Ratio	21.17	1.83	0.98	2.18	4.22
Interest Coverage	-1,269.50	60.93	3.29	60.40	211.80

Operating Efficiency Ratios

	Rajnish Wellness	Emami	Zydus Wellness	Jyothy Labs	Bajaj Consumer
Debtors to sales (%)	11.48	8.77	5.67	6.14	7.35
Asset Turnover	1.68	1.06	0.50	1.41	1.37
Receivable days	59.22	38.37	32.76	25.54	23.11
Inventory Days	29.64	34.17	55.91	32.35	18.94
Payable days	8.58	146.36	103.68	70.92	36.67
Cash Conversion Cycle	80.28	-73.82	-15.02	-13.03	5.38

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly